Ensign Group Stock (NASDAQ:ENSG)


ForecastRevenueOwnershipFinancialsChartTranscripts

Previous Close

$209.65

52W Range

$118.73 - $218.00

50D Avg

$191.99

200D Avg

$172.73

Market Cap

$12.23B

Avg Vol (3M)

$387.77K

Beta

0.80

Div Yield

$0.25 (0.12%)

ENSG Company Profile


The Ensign Group, Inc. provides health care services in the post-acute care continuum and other ancillary businesses. The company operates in two segments, Skilled Services and Real Estate. The company offers skilled services, which include short and long-term nursing care services for patients with chronic conditions, prolonged illness, and the elderly; and physical, occupational, and speech therapies and other rehabilitative and healthcare services. It also provides standard services, such as room and board, special nutritional programs, social, recreational, entertainment, and other services. In addition, the company offers senior living, as well as mobile diagnostics services; leases real estate properties; and provides other ancillary services consisting of digital x-ray, ultrasound, electrocardiogram, laboratory, sub-acute, and patient transportation services to people in their homes or at long-term care facilities. As of April 4, 2022, it operated 252 healthcare facilities in Arizona, California, Colorado, Idaho, Iowa, Kansas, Nebraska, Nevada, South Carolina, Texas, Utah, Washington, and Wisconsin. The company was incorporated in 1999 and is based in San Juan Capistrano, California.

Show More

Industry

Medical - Care Facilities

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

39,300

IPO Date

Nov 09, 2007

Website

ENSG Performance


Revenue Breakdown


Revenue Breakdown by Product/Service

Product/ServiceDec 25Dec 24Dec 23
Standard Bearer Segment$126.93M--
Skilled Services Segment$4.84B--
Rental-$95.09M$21.28M
Service-$4.24B$3.71B

Fiscal year ends in Dec 25 | Currency in USD

ENSG Financial Summary


Dec 25Dec 24Dec 23
Revenue$5.06B$4.26B$3.73B
Operating Income$425.31M$358.30M$255.37M
Net Income$343.97M$297.97M$209.40M
EBITDA$551.67M$478.52M$353.24M
Basic EPS$6.00$5.26$3.76
Diluted EPS$5.84$5.12$3.65

Fiscal year ends in Dec 25 | Currency in USD

Latest Earnings Call Transcripts


Q4 25Feb 05, 26 | 1:00 PM
Q3 25Nov 04, 25 | 1:00 PM
Q2 25Jul 25, 25 | 1:00 PM

Peer Comparison


TickerCompany
EHCEncompass Health Corporation
EXELExelixis, Inc.
DVADaVita Inc.
QGENQiagen N.V.
RVTYRevvity, Inc.
UHSUniversal Health Services, Inc.
ALGNAlign Technology, Inc.
SOLVSolventum Corporation
ELANElanco Animal Health Incorporated
BMRNBioMarin Pharmaceutical Inc.